Titlebook: Resistance of Cancer Cells to CTL-Mediated Immunotherapy; Benjamin Bonavida,Salem Chouaib Book 2015 Springer International Publishing Swit

只看該作者 · 發(fā)表于 2025-3-31 02:20:18

Overcoming Cancer Cell Resistance to Death Receptor Targeted Therapiesracterized by an intracellular death domain, which transmits a death signal from their cognate ligands, including TNF-related apoptosis inducing ligand (TRAIL). Currently, multiple clinical trials are underway to evaluate the antitumor activity of recombinant human TRAIL and agonistic antibodies to

只看該作者 · 發(fā)表于 2025-3-31 08:33:15

只看該作者 · 發(fā)表于 2025-3-31 11:36:43

Epithelial Mesenchymal Transition Influence on CTL Activity to promote invasion and metastasis. This review critically assesses whether EMT confers stemness, resistance to chemo- and targeted therapeutics, and immune escape. EMT inducers share common targets that alter apico-basal polarity, intercellular adhesion and the actin cytoskeleton, events that also

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-11-2 23:50
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved